NCT02137109View on ClinicalTrials.gov

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Multiple Sclerosis

Interventions

DRUG

natalizumab

Administered as specified in the treatment arm.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY